Valeant Pharmaceuticals To Hold Conference Call To Announce 2015 Financial Guidance

Dec 15, 2014, 16:30 ET from Valeant Pharmaceuticals International, Inc.

LAVAL, Quebec, Dec. 15, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Thursday, January 8, 2015 at 8:00 a.m. ET (5:00 a.m. PT) to announce 2015 financial guidance.

The dial-in number to participate on this call is (877) 876-8393, confirmation code 54415766. International callers should dial (973) 200-3961, confirmation code 54415766. A replay will be available approximately two hours following the conclusion of the conference call to January 15, 2014, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 54415766.

The webcast and slide presentation will be hosted in the Investor Relations section of its corporate web site at Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at

Contact Information:
Laurie W. Little

Logo -

SOURCE Valeant Pharmaceuticals International, Inc.